Cationic Porphyrins and Analogues as New DNA Topoisomerase I and II Inhibitors

被引:25
作者
Shuai, Li [1 ]
Wang, Shaoru [1 ]
Zhang, Lixia [1 ]
Fu, Boqiao [1 ]
Zhou, Xiang [1 ]
机构
[1] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China
关键词
BINDING; PHTHALOCYANINE; TELOMERASE; MECHANISM;
D O I
10.1002/cbdv.200800083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of cationic porphyrins. and analogues such as cationic corroles and phthalocyanines were found to have biological activities towards topoisomerases I and II in vitro. Cationic porphyrins and phthalocyanines do not induce Topo I-DNA covalent complexes but inhibit topoisomerase I by direct binding to DNA, which limits topoisomerase I access to the DNA substrate. The lowest concentration where in inhibition effect is clearly visible of some derivatives is between 0.1 and 0.6 mu M. Furthermore, some complexes Were found 10 inhibit the activity of the topoisomerase II
引用
收藏
页码:827 / 837
页数:11
相关论文
共 15 条
[1]   Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I [J].
Boege, F ;
Straub, T ;
Kehr, A ;
Boesenberg, C ;
Christiansen, K ;
Andersen, A ;
Jakob, F ;
Kohrle, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2262-2270
[2]   Synthesis of β-substituted cationic porphyrins and their interactions with DNA [J].
Chen, B ;
Qin, W ;
Wang, P ;
Tian, T ;
Ma, HJ ;
Cao, XP ;
Wu, XJ ;
Zhou, X ;
Zhang, XL ;
Liu, F ;
Zheng, F ;
Li, X .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (21) :3731-3733
[3]   DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition [J].
Fortune, JM ;
Velea, L ;
Graves, DE ;
Utsugi, T ;
Yamada, Y ;
Osheroff, N .
BIOCHEMISTRY, 1999, 38 (47) :15580-15586
[4]   DNA binding and catalytic properties of positively charged corroles [J].
Gershman, Zoya ;
Goldberg, Israel ;
Gross, Zeev .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (23) :4320-4324
[5]   Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity [J].
Habermeyer, M ;
Fritz, J ;
Barthehnes, HU ;
Christensen, MO ;
Larsen, MK ;
Boege, F ;
Marko, D .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (09) :1395-1404
[6]   Binding mode and affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay [J].
McKnight, Ruel E. ;
Gleason, Aaron B. ;
Keyes, James A. ;
Sahabi, Sadia .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) :1013-1017
[7]   Topoisomerase I inhibitors: camptothecins and beyond [J].
Pommier, Yves .
NATURE REVIEWS CANCER, 2006, 6 (10) :789-802
[8]   Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors [J].
Raspaglio, G ;
Ferlini, C ;
Mozzetti, S ;
Prislei, S ;
Gallo, D ;
Das, N ;
Scambia, G .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (01) :113-121
[9]   Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA [J].
Redinbo, MR ;
Stewart, L ;
Kuhn, P ;
Champoux, JJ ;
Hol, WGJ .
SCIENCE, 1998, 279 (5356) :1504-1513
[10]   Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA [J].
Redinbo, MR ;
Champoux, JJ ;
Hol, WGJ .
BIOCHEMISTRY, 2000, 39 (23) :6832-6840